NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV
Post# of 87
(Total Views: 964)
Posted On: 09/17/2019 4:13:13 PM
NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Enters Distribution Agreement to Launch Medical Cannabis Inhaler in Canada
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered into a distribution agreement with Israel-based pharma-tech company Syqe Medical, Ltd. to launch Syqe’s flagship product, the Syqe(TM) Inhaler, in Canada. The Syqe Inhaler is a metered-dose medical cannabis inhaler that provides quick pain relief while decreasing psychoactive effects and enabling patients to go about their normal daily activities. The inhaler’s use of metered dosing allows patients and healthcare providers to consistently deliver treatment at pharmaceutical standards. Through its wholly owned subsidiaries, TerrAscend Canada and Solace Health Network, TerrAscend will undertake marketing, distribution, and sales efforts of the Syqe Inhaler. “We continue to be thrilled with the steps TerrAscend is taking to build an industry-leading business that spans retail, manufacturing, distribution, biotechnology, and now health tech,” Canopy Rivers president and CEO Narbe Alexandrian stated in the news release. “We believe that TerrAscend is uniquely positioned in the Canadian market to deliver on the consumer demand for innovative and rigorously tested products like the Syqe device.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered into a distribution agreement with Israel-based pharma-tech company Syqe Medical, Ltd. to launch Syqe’s flagship product, the Syqe(TM) Inhaler, in Canada. The Syqe Inhaler is a metered-dose medical cannabis inhaler that provides quick pain relief while decreasing psychoactive effects and enabling patients to go about their normal daily activities. The inhaler’s use of metered dosing allows patients and healthcare providers to consistently deliver treatment at pharmaceutical standards. Through its wholly owned subsidiaries, TerrAscend Canada and Solace Health Network, TerrAscend will undertake marketing, distribution, and sales efforts of the Syqe Inhaler. “We continue to be thrilled with the steps TerrAscend is taking to build an industry-leading business that spans retail, manufacturing, distribution, biotechnology, and now health tech,” Canopy Rivers president and CEO Narbe Alexandrian stated in the news release. “We believe that TerrAscend is uniquely positioned in the Canadian market to deliver on the consumer demand for innovative and rigorously tested products like the Syqe device.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Scroll down for more posts ▼